The Cooper Companies, Inc. (NASDAQ:COO) Given Average Rating of “Hold” by Brokerages

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been assigned an average recommendation of “Hold” from the fifteen research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, six have given a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $90.3077.

Several research analysts have recently commented on COO shares. JPMorgan Chase & Co. boosted their price target on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. Robert W. Baird lifted their target price on Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research note on Friday, December 5th. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research report on Friday, December 5th. Finally, The Goldman Sachs Group reiterated a “sell” rating and set a $73.00 price objective on shares of Cooper Companies in a research note on Friday, January 9th.

Cooper Companies Stock Down 1.8%

NASDAQ COO opened at $81.29 on Monday. The firm has a market capitalization of $15.93 billion, a price-to-earnings ratio of 43.24, a PEG ratio of 2.37 and a beta of 1.03. Cooper Companies has a 52 week low of $61.78 and a 52 week high of $100.24. The company has a fifty day moving average of $80.24 and a two-hundred day moving average of $74.03. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the previous year, the firm earned $1.04 earnings per share. The business’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, analysts predict that Cooper Companies will post 3.98 earnings per share for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Cynthia L. Lucchese purchased 1,784 shares of the firm’s stock in a transaction on Monday, December 22nd. The stock was bought at an average cost of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the purchase, the director owned 9,445 shares in the company, valued at $793,946.70. This represents a 23.29% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Holly R. Sheffield purchased 1,230 shares of the stock in a transaction on Tuesday, December 16th. The stock was acquired at an average cost of $80.75 per share, with a total value of $99,322.50. Following the acquisition, the insider owned 39,052 shares of the company’s stock, valued at approximately $3,153,449. This represents a 3.25% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 16,014 shares of company stock valued at $1,304,416. Corporate insiders own 1.98% of the company’s stock.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently modified their holdings of COO. Buckhead Capital Management LLC raised its stake in shares of Cooper Companies by 14.3% in the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock worth $4,040,000 after purchasing an additional 7,368 shares during the last quarter. First American Bank acquired a new position in Cooper Companies in the 3rd quarter worth approximately $1,646,000. Amundi increased its holdings in Cooper Companies by 35.5% in the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock worth $97,225,000 after buying an additional 348,652 shares during the period. Thompson Investment Management Inc. purchased a new position in Cooper Companies during the 3rd quarter worth approximately $3,728,000. Finally, Westwood Holdings Group Inc. lifted its stake in Cooper Companies by 23.4% during the 2nd quarter. Westwood Holdings Group Inc. now owns 311,745 shares of the medical device company’s stock valued at $22,184,000 after acquiring an additional 59,190 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.